Eugene Suh

656 total citations · 1 hit paper
9 papers, 385 citations indexed

About

Eugene Suh is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Eugene Suh has authored 9 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Public Health, Environmental and Occupational Health, 4 papers in Hematology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Eugene Suh's work include Acute Lymphoblastic Leukemia research (5 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Palliative Care and End-of-Life Issues (3 papers). Eugene Suh is often cited by papers focused on Acute Lymphoblastic Leukemia research (5 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Palliative Care and End-of-Life Issues (3 papers). Eugene Suh collaborates with scholars based in United States and Canada. Eugene Suh's co-authors include Paul C. Nathan, Jennifer S. Ford, Kevin C. Oeffinger, Tara O. Henderson, Jennifer L. McNeer, Kayla Stratton, Charles A. Sklar, David R. Freyer, Wendy Stock and Leslie L. Robison and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Internal Medicine.

In The Last Decade

Eugene Suh

9 papers receiving 379 citations

Hit Papers

Late mortality and chronic health conditions in long-term... 2020 2026 2022 2024 2020 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eugene Suh United States 6 270 179 111 89 77 9 385
Karen E. Effinger United States 11 232 0.9× 152 0.8× 89 0.8× 67 0.8× 72 0.9× 30 337
Kayla Stratton United States 3 367 1.4× 222 1.2× 129 1.2× 87 1.0× 73 0.9× 8 457
Sandra Brooks United States 5 333 1.2× 221 1.2× 95 0.9× 78 0.9× 51 0.7× 8 400
Léonie Casagranda France 11 218 0.8× 175 1.0× 77 0.7× 32 0.4× 50 0.6× 21 294
Ken Bishop United Kingdom 2 307 1.1× 185 1.0× 108 1.0× 75 0.8× 61 0.8× 4 395
Rachel Hollis United Kingdom 10 200 0.7× 121 0.7× 55 0.5× 82 0.9× 42 0.5× 25 419
Maria Winther Gunnes Norway 7 153 0.6× 117 0.7× 58 0.5× 46 0.5× 45 0.6× 8 273
Stacy Cooper United States 12 262 1.0× 264 1.5× 39 0.4× 118 1.3× 61 0.8× 34 516
Þorgerður Guðmundsdóttir Denmark 8 236 0.9× 157 0.9× 38 0.3× 41 0.5× 52 0.7× 13 291
Tyler G. Ketterl United States 8 127 0.5× 75 0.4× 54 0.5× 65 0.7× 24 0.3× 27 262

Countries citing papers authored by Eugene Suh

Since Specialization
Citations

This map shows the geographic impact of Eugene Suh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugene Suh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugene Suh more than expected).

Fields of papers citing papers by Eugene Suh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eugene Suh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugene Suh. The network helps show where Eugene Suh may publish in the future.

Co-authorship network of co-authors of Eugene Suh

This figure shows the co-authorship network connecting the top 25 collaborators of Eugene Suh. A scholar is included among the top collaborators of Eugene Suh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eugene Suh. Eugene Suh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
O’Brien, Maureen M., Jennifer L. McNeer, Susan R. Rheingold, et al.. (2023). A phase 3 trial of inotuzumab ozogamicin for high-risk B-ALL: Second safety phase results from Children’s Oncology Group AALL1732.. Journal of Clinical Oncology. 41(16_suppl). 10016–10016. 11 indexed citations
2.
Suh, Eugene, et al.. (2023). An Atypical Presentation of Hodgkin Lymphoma Invading the Myocardium. Journal of Pediatric Hematology/Oncology. 45(6). 349–351. 1 indexed citations
3.
McNeer, Jennifer L., Maureen M. O’Brien, Susan R. Rheingold, et al.. (2021). A Phase 3 Randomized Trial of Inotuzumab Ozogamicin for Newly Diagnosed High-Risk B-ALL: Safety Phase Results from Children's Oncology Group Protocol AALL1732. Blood. 138(Supplement 1). 3398–3398. 8 indexed citations
4.
Suh, Eugene, Kayla Stratton, Wendy M. Leisenring, et al.. (2020). Late mortality and chronic health conditions in long-term survivors of early-adolescent and young adult cancers: a retrospective cohort analysis from the Childhood Cancer Survivor Study. The Lancet Oncology. 21(3). 421–435. 205 indexed citations breakdown →
5.
Hemenway, Charles S., et al.. (2019). Emergence of a Ph-negative Clone in a Child With Ph+ ALL. Journal of Pediatric Hematology/Oncology. 42(6). e466–e468. 1 indexed citations
6.
Suh, Eugene, et al.. (2019). Neonatal Hemophagocytic Lymphohistiocytosis. NeoReviews. 20(6). e316–e325. 16 indexed citations
7.
Suh, Eugene, Julia R. Trosman, Tara O. Henderson, et al.. (2018). “Getting to know you and your child” screening questionnaire: Results from a Chicago pediatric collaborative.. Journal of Clinical Oncology. 36(15_suppl). e22515–e22515. 1 indexed citations
8.
Suh, Eugene, Christopher K. Daugherty, Kristen Wroblewski, et al.. (2014). General Internists’ Preferences and Knowledge About the Care of Adult Survivors of Childhood Cancer. Annals of Internal Medicine. 160(1). 11–17. 129 indexed citations
9.
Suh, Eugene, et al.. (2004). Evaluation of a pharmacist pain management education program and associated medication use in a palliative care population. American Journal of Health-System Pharmacy. 61(3). 277–280. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026